Caricamento...
Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
INTRODUCTION: Pembrolizumab cause immune‐related adverse events. We herein report a case of advanced bladder cancer, who treated with pembrolizumab and exhibited intriguing clinical course. CASE PRESENTATION: A 63‐year‐old man with bladder carcinoma was treated by radical cystectomy, however, the bl...
Salvato in:
| Pubblicato in: | IJU Case Rep |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292166/ https://ncbi.nlm.nih.gov/pubmed/32743459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12128 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|